PFG
36
3
FIS
46
-9
AN
47
3
AAP
30
3
AVY
53
3
CPB
30
5
FRT
41
5
JPM
59
3
HIG
54
2
BIIB
38
2
EXR
57
7
DFS
60
4
HBI
52
2
AON
49
2
KR
44
4
BDX
41
3
GS
63
11
IRM
68
5
TSN
39
5
EBAY
43
3
PFG
36
3
FIS
46
-9
AN
47
3
AAP
30
3
AVY
53
3
CPB
30
5
FRT
41
5
JPM
59
3
HIG
54
2
BIIB
38
2
EXR
57
7
DFS
60
4
HBI
52
2
AON
49
2
KR
44
4
BDX
41
3
GS
63
11
IRM
68
5
TSN
39
5
EBAY
43
3
Financhill
Back

Genmab AS Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
33

GNMSF
Genmab AS

Last Price:
220.28
Seasonality Move:
-0.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 7.4% based on the past 9 years of stock performance.
  • Genmab AS has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GNMSF] share price is $220.28. The Score for GNMSF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 7.4% based on the past 9 years of stock performance.

Genmab AS Stock Rating

Sell
33
Genmab AS (GNMSF) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Genmab AS Stock Price History

Is GNMSF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
334.33
52-Week Low:
211.82

Prediction Charts

Market Cap:
13.99B
Price in USD:
220.28
Volume:
1.33K
Beta:
0.64

Technical Analysis

SMA50:
245.41
SMA100:
254.11
SMA200:
270.40
52-Wk Change:
-23.46%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 220.28 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 222.75 222.75 231.90 220.20
Oct-18 232.31 232.31 232.31 223.19
Oct-21 231.60 224.00 232.27 219.90
Oct-22 223.00 218.93 231.05 218.93
Oct-23 229.71 226.66 232.91 220.75
Oct-24 232.15 229.71 232.15 219.95
Oct-25 232.21 230.24 232.36 216.84
Oct-28 230.25 225.00 231.62 225.00
Oct-29 223.32 223.32 230.39 223.32
Oct-30 221.20 221.20 230.00 221.20
Oct-31 227.53 218.47 227.53 215.45
Nov-1 229.98 220.72 229.98 220.72
Nov-4 229.34 226.00 229.34 218.70
Nov-5 220.28 220.28 229.07 218.81

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.